Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease: A Randomized, Double-Blind and Placebo-Controlled Crossover Study

NCT04589182 is registered in ClinicalTrials.gov with Christian Baumann as lead sponsor.

NCT NCT04589182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04589182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease: A Randomized, Double-Blind and Placebo-Controlled Crossover Study
Lead sponsor
Christian Baumann
Phase
Not applicable
Overall status
Unknown status
Start date
October 20, 2020
Completion date
October 31, 2022
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease, mild cognitive impairment, parkinson disease